Stephanie J Brister

Title: Stephanie J Brister: Innovator in Thrombin Inhibition

Introduction

Stephanie J Brister is a notable inventor based in Hamilton, CA. She has made significant contributions to the field of biochemistry, particularly in the area of thrombin inhibition. Her innovative work has the potential to impact medical treatments related to blood coagulation.

Latest Patents

Stephanie holds a patent for "Dermatan disulfate, an inhibitor of thrombin generation and activation." This patent describes a method of inhibiting thrombin generation and complement activation by utilizing a dermatan sulfate that has at least two sulfate groups per disaccharide. The dermatan sulfate is obtained through chemical sulfation of native dermatan sulfate. The resulting compound has an average molecular weight ranging from about 5000 to 35000 Daltons. It is characterized by a high content of L-iduronic → 4,6-di-O-sulfated N-acetyl-D-galactosamine residues, and exhibits specific heparin cofactor II-mediated anti-thrombin activity, which varies between about 25 to 125 U/mg depending on the average molecular weight.

Career Highlights

Throughout her career, Stephanie has focused on advancing the understanding of thrombin and its role in coagulation. Her research has led to innovative solutions that could enhance therapeutic approaches in treating thrombotic disorders.

Collaborations

Stephanie has collaborated with esteemed colleagues, including Michael R Buchanan and Robert J Linhardt. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.

Conclusion

Stephanie J Brister is a pioneering inventor whose work in thrombin inhibition showcases her commitment to advancing medical science. Her contributions are significant and have the potential to lead to important advancements in therapeutic treatments.